Literature DB >> 9261405

Bovine papillomavirus type 1 DNA replication: the transcriptional activator E2 acts in vitro as a specificity factor.

C Bonne-Andréa1, F Tillier, G D McShan, V G Wilson, P Clertant.   

Abstract

We previously devised cell-free conditions supporting efficient replication of bovine papillomavirus type 1 (BPV1) DNA (C. Bonne-Andréa, S. Santucci, and P. Clertant, J. Virol. 69:3201-3205, 1995): the use of highly active preparations of viral initiator protein E1, together with extract from a particular cell source, allowed the synthesis of complete DNA circles through successive rounds of replication; this occurred in the absence of the viral transcriptional activator E2, required in vivo for the replication of viral genomes. We now report that adding E2 to cell-free assays produced only slight effects both on the yield of E1-dependent DNA synthesis and on the quality of newly made DNA molecules when a template carrying a wild-type BPV1 replication origin (ori) was used. The performance of mouse cell extracts, unable to sustain efficient BPV1 DNA replication in the presence of E1 only, was likewise not improved by the addition of E2. In a proper in vitro environment, E1 is thus fully capable of efficiently initiating viral DNA synthesis by itself, an activity which is not enhanced by interaction with E2. An important effect, however, was detected: E2 totally suppressed the nonspecific replication of ori-defective DNA templates, otherwise observed in high E1 concentrations. We examined the requirements for building a minimal DNA sequence behaving in vitro as a specific ori sequence under stringent recognition conditions, i.e., in the presence of both E1 and E2. Only two elements, the 18-bp E1 binding palindrome and an AT-rich sequence, were required in cis to allow specific cell-free DNA replication; there seemed to be no need for an E2 binding site to ensure discrimination between specific ori templates and other DNA molecules, even in the presence of E2. This suggests that during the initiation of BPV1 DNA replication, at least in vitro, E2 acts as a specificity factor restricting the action of E1 to a defined ori sequence; this function, likely not demanding the direct binding of E2 to cognate DNA sites, might primarily involve protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261405      PMCID: PMC191961     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Regulation of DNA replication in vitro by the transcriptional activation domain of GAL4-VP16.

Authors:  L Z Cheng; J L Workman; R E Kingston; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

2.  Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 trans-activator.

Authors:  S S Prakash; S R Grossman; R B Pepinsky; L A Laimins; E J Androphy
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

3.  Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication.

Authors:  M K Ferguson; M R Botchan
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase.

Authors:  P Park; W Copeland; L Yang; T Wang; M R Botchan; I J Mohr
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

5.  Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells.

Authors:  S Santucci; E J Androphy; C Bonne-Andréa; P Clertant
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein encoded by bovine papillomavirus type 1.

Authors:  S Sun; L Thorner; M Lentz; P MacPherson; M Botchan
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.

Authors:  C M Chiang; M Ustav; A Stenlund; T F Ho; T R Broker; L T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  Replication of bovine papillomavirus type 1 origin-containing DNA in crude extracts and with purified proteins.

Authors:  F Müller; Y S Seo; J Hurwitz
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

9.  Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts.

Authors:  S R Kuo; J S Liu; T R Broker; L T Chow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

10.  Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1.

Authors:  M Ustav; E Ustav; P Szymanski; A Stenlund
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  16 in total

1.  Identification of a short, hydrophilic amino acid sequence critical for origin recognition by the bovine papillomavirus E1 protein.

Authors:  A Gonzalez; C Bazaldua-Hernandez; M West; K Woytek; V G Wilson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 3.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

4.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response.

Authors:  Amélie Fradet-Turcotte; Fanny Bergeron-Labrecque; Cary A Moody; Michaël Lehoux; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

6.  Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin.

Authors:  S Titolo; A Pelletier; F Sauvé; K Brault; E Wardrop; P W White; A Amin; M G Cordingley; J Archambault
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway.

Authors:  Marie-Helene Malcles; Nathalie Cueille; Francisca Mechali; Olivier Coux; Catherine Bonne-Andrea
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2.

Authors:  N Cueille; R Nougarede; F Mechali; M Philippe; C Bonne-Andrea
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  Characterization of the minimal DNA binding domain of the human papillomavirus e1 helicase: fluorescence anisotropy studies and characterization of a dimerization-defective mutant protein.

Authors:  S Titolo; K Brault; J Majewski; P W White; J Archambault
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Genomic instability of the host cell induced by the human papillomavirus replication machinery.

Authors:  Meelis Kadaja; Alina Sumerina; Tatjana Verst; Mari Ojarand; Ene Ustav; Mart Ustav
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.